Cancer patients face elevated risk of carrying antimicrobial resistant 'superbugs'

Franklin lakes, n.j. , may 21, 2025 /prnewswire/ -- first-of-their-kind studies published in the lancet oncology 1 and cancer medicine 2 provide new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant (amr) infections compared to all other non-cancer patients.
BDX Ratings Summary
BDX Quant Ranking